Luo Hsuan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Luo hsuan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Luo Hsuan Today - Breaking & Trending Today

USFDA recognized Antrodia cinnamomea mycelia (NDIN No.1170)


USFDA NDI notification of Antromax Antrodia cinnamomea mycelia
BriefingWire.com, 5/23/2021 -
The history of Antrodia cinnamomea consumption by indigenous tribes in Taiwan dates back two hundred years ago, while people in the Western world know little about this ingredient. The USFDA NDI acknowledgement without objection to Greenyn s Antromax was the 1st notification after numerous attempts in the past 14 years. We are honored to establish a stepping-stone for the A. cinnamomea to the US health markets estimated at 10 billion US dollars.
USFDA acknowledged Antrodia cinnamomea as new dietary ingredients
On April 12th, Greenyn Biotechnology Corporation hosted a seminar - The international development of Taiwan s Antrodia cinnamomea and its clinical application, and announced Antromax s acknowledgement without objection by USFDA NDI. It was a great feat for Greenyn, and will certainly boost the morale of the Antrodia industry to de ....

United States , Luo Hsuan , Greenyn Antromax , Antromax Antrodia , Greenyn Biotechnology Corporation , Physician Of China Medical University Hospital , Hsu Pang Kuei , Kao Shung Te , Attending Physician , China Medical University Hospital , Press Release , Press Releases , Ree Press Release , Ree Press Releases , Ree Pr , Ree Press Release Sites , Ree Press Release Websites , Ress Release Submission , Ree Press Release Submission , Ress Release Submission Sites , Ree Press Release Submission Sites , Ree Press Release Submission Service , Ress Release Distribution , Ree Press Release Distribution , Ress Release Distribution Sites , Ree Press Release Distribution Sites ,

USFDA recognized Antrodia cinnamomea mycelia (NDIN No.1170)


USFDA recognized Antrodia cinnamomea mycelia (NDIN No.1170)
USFDA NDI notification of Antromax Antrodia cinnamomea mycelia
TAIPEI, May 20, 2021 - (ACN Newswire) - The history of Antrodia cinnamomea consumption by indigenous tribes in Taiwan dates back two hundred years ago, while people in the Western world know little about this ingredient. The USFDA NDI acknowledgement without objection to Greenyn s Antromax was the 1st notification after numerous attempts in the past 14 years. We are honored to establish a stepping-stone for the A. cinnamomea to the US health markets estimated at 10 billion US dollars.
Dr. Kao Shung-te (middle) of China Medical University Hospital and Dr. Houng Jer-yiing (left) of I-Shou University Medical School presented the study results of the randomized double-blind clinical trial and the bioavailability of Antromax in different dosages forms, respectively. ....

T Ai Pei , United States , Kostenloser Wertpapierhandel , Luo Hsuan , Nick Chen , Greenyn Antromax , Antromax Antrodia , University Medical School , Greenyn Biotechnology Co , Greenyn Biotechnology Corporation , Physician Of China Medical University Hospital , China Medical University Hospital , Kao Shung Te , Houng Jer Yiing , I Shou University Medical School , Greenyn Biotechnology , Hsu Pang Kuei , Attending Physician , Associate Dean , Central Taiwan Science Park , Southeast Asian , டி ஐ பேய் , ஒன்றுபட்டது மாநிலங்களில் , நிக் சென் , பல்கலைக்கழகம் மருத்துவ பள்ளி , சீனா மருத்துவ பல்கலைக்கழகம் மருத்துவமனை ,

Business Scoop » USFDA Recognized Antrodia Cinnamomea Mycelia (NDIN No.1170)


Press Release – ACN Newswire
The history of Antrodia cinnamomea consumption by indigenous tribes in Taiwan dates back two hundred years ago, while people in the Western world know little about this ingredient. The USFDA NDI acknowledgement without objection to Greenyn’s Antromax …The history of Antrodia cinnamomea consumption by indigenous tribes in Taiwan dates back two hundred years ago, while people in the Western world know little about this ingredient. The USFDA NDI acknowledgement without objection to Greenyn’s Antromax was the 1st notification after numerous attempts in the past 14 years. We are honored to establish a stepping-stone for the A. cinnamomea to the US health markets estimated at 10 billion US dollars. ....

United States , Luo Hsuan , Greenyn Antromax , University Medical School , Greenyn Biotechnology Corporation , Physician Of China Medical University Hospital , China Medical University Hospital , Press Release , Kao Shung Te , Houng Jer Yiing , I Shou University Medical School , Hsu Pang Kuei , Attending Physician , Associate Dean , Central Taiwan Science Park , Southeast Asian , New Zealand , ஒன்றுபட்டது மாநிலங்களில் , பல்கலைக்கழகம் மருத்துவ பள்ளி , சீனா மருத்துவ பல்கலைக்கழகம் மருத்துவமனை , ப்ரெஸ் வெளியீடு , ஶூ வேதனை கூயெ , கலந்துகொள்வது மருத்துவர் , இணை டீன் , மைய டைவாந் அறிவியல் பூங்கா , தென்கிழக்கு ஆசிய ,

Hmedium: Taiwan's Antrodia cinnamomea Gains World Recognition


Hmedium: Taiwan s Antrodia cinnamomea Gains World Recognition
Greenyn Biotechnology received USFDA NDI acknowledgement without objection for Antrodia cinnamomea mycelia Antromax
Taipei, Taiwan (Newsfile Corp. - May 12, 2021) - On April 12th, Greenyn Biotechnology Corporation hosted a seminar - The international development of Taiwan s
Antrodia cinnamomea and its clinical application, and announced Antromax s acknowledgement without objection by USFDA NDI. It was a great feat for Greenyn, and will certainly boost the morale of the Antrodia industry to devote more resources in the US market.
A. cinnamomea is an edible fungus that grows on the endangered
Cinnamomum kanehirae tree, which is found only in Taiwan. This indigenous fungus is traditionally used to ameliorate liver disorders, hangovers, fatigue, and enhance immunity. Ruby of Taiwan was given to this miracle fungus. ....

T Ai Pei , United States , Kostenloser Wertpapierhandel , Luo Hsuan , Wayne Wei , Taiwan Newsfile Corp , University Medical School , Greenyn Biotechnology Co , Greenyn Biotechnology Corporation , Physician Of China Medical University Hospital , China Medical University Hospital , Greenyn Biotechnology , Kao Shung Te , Houng Jer Yiing , I Shou University Medical School , Hsu Pang Kuei , Attending Physician , Associate Dean , Central Taiwan Science Park , Southeast Asian , டி ஐ பேய் , ஒன்றுபட்டது மாநிலங்களில் , பல்கலைக்கழகம் மருத்துவ பள்ளி , சீனா மருத்துவ பல்கலைக்கழகம் மருத்துவமனை , ஶூ வேதனை கூயெ , கலந்துகொள்வது மருத்துவர் ,